Biomedical Research on Cancer and other Life-Threatening Diseases
Genentech’s biomedical research on cancer and other life-threatening diseases has helped a lot of people around the world. Cancer patients were given fresh lease of life through medicines and bioech products that were developed through biomedical research.
Biotechnology, through molecular biology, studies the causes of diseases and other body abnormalities at the molecular level. It views the human being as a collections of molecules. Through pharmacogenomics, it studies on how the individual’s genetic inheritance affects his body’s response to drugs. Understanding the human body in molecular terms can greatly help in the development of medicines to treat ailments and diseases that are believed to originate inside the molecules.
Considered as the founder of biotechnology, Genentech is now among the leading biotech companies in the world with 30 years experience in pioneering biomedical research. Using human genetic information, Genentech has discovered, developed and manufactured medicines and biotech products for serious diseases such as cancer and other life-threatening diseases. Currently, it has more than 100 projects in the pipeline that are focused on discovering and developing therapeutic medicines in areas of oncology, infectious diseases, immunology, neuroscience, and disorders of tissue growth and repair.
Genentech’s Research Department is a world-class research organization of 1,100 dedicated scientists, researchers, and postdocs that are rigorously working on various groundbreaking scientific activities in molecular biology, protein chemistry, bioinformatics, and small molecule drug discovery.
As a pioneer in biotechnology, Genentech has discovered, developed and manufactured medicines that have helped millions of people around the world. And still more will be benefited by its ongoing research and development projects in the future.